Q&A with Timothy Albertson on the antibodies President Trump received, clinical trials and the goals
Timothy Albertson, chair of internal medicine and specialist in pulmonary and critical care, is leading one of UC Davis Health’s two trials of Regeneron Pharmaceuticals’ antibody cocktail. He answers questions about the trials, the antibodies and how they might work.
In a new COVID-19 clinical trial, UC Davis Health tests the same REGN-COV2 antibody combination given to President Trump
In a new clinical trial, UC Davis Health will test the effectiveness and safety of REGN-COV2, the monoclonal antibody cocktail, in preventing COVID-19 in adults living with infected patients. The drug was recently administered to President Donald Trump as part of his treatment for SAR-CoV-2 infection.
In mid-March, researchers at UC Davis were asked to adjust or reduce their work when possible in order to limit social contact and minimize the spread of the novel coronavirus. This “ramp down” meant that some campus research was postponed.
Facilities Management and researchers are collecting and analyzing samples from the campus sewer system as one more tool to potentially identify and halt an outbreak of COVID-19.
Samples collected so far — all at the wastewater treatment plant — have returned mostly negative results. The team occasionally detected low levels of the coronavirus in samples collected in late August and September, consistent with cases of COVID-19 reported by the campus.
A $3.7 million NIH grant will help reach underserved and vulnerable populations
Four UC Davis research centers will share a $3.7 million grant to offer free COVID-19 testing for agricultural workers in the Central Valley, where the coronavirus pandemic has reached alarming levels, the National Institutes of Health (NIH) announced Wednesday.
Vaccines Will Help, but Masks and Social Distancing Will Be Crucial for Many Months
Although COVID-19 science has raced forward, the pandemic is likely to have an enormous impact on our lives deep into 2021, even with a vaccine on the horizon next year, two top UC Davis Health experts said this week on UC Davis LIVE: COVID-19.
Laboratory tests of surgical and N95 masks by researchers at the University of California, Davis, show that they do cut down the amount of aerosolized particles emitted during breathing, talking and coughing. Tests of homemade cloth face coverings, however, show that the fabric itself releases a large amount of fibers into the air, underscoring the importance of washing them. The work is published Sept. 24 in Scientific Reports.